Article

Regulation of pancreatic cancer cell migration and invasion by RhoC GTPase and Caveolin-1

Division of Hematology-Oncology, Department of Internal Medicine, The University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan 48109, USA.
Molecular Cancer (Impact Factor: 5.4). 02/2005; 4(1):21. DOI: 10.1186/1476-4598-4-21
Source: PubMed

ABSTRACT In the current study we investigated the role of caveolin-1 (cav-1) in pancreatic adenocarcinoma (PC) cell migration and invasion; initial steps in metastasis. Cav-1 is the major structural protein in caveolae; small Omega-shaped invaginations within the plasma membrane. Caveolae are involved in signal transduction, wherein cav-1 acts as a scaffolding protein to organize multiple molecular complexes regulating a variety of cellular events. Recent evidence suggests a role for cav-1 in promoting cancer cell migration, invasion and metastasis; however, the molecular mechanisms have not been described. The small monomeric GTPases are among several molecules which associate with cav-1. Classically, the Rho GTPases control actin cytoskeletal reorganization during cell migration and invasion. RhoC GTPase is overexpressed in aggressive cancers that metastasize and is the predominant GTPase in PC. Like several GTPases, RhoC contains a putative cav-1 binding motif.
Analysis of 10 PC cell lines revealed high levels of cav-1 expression in lines derived from primary tumors and low expression in those derived from metastases. Comparison of the BxPC-3 (derived from a primary tumor) and HPAF-II (derived from a metastasis) demonstrates a reciprocal relationship between cav-1 expression and p42/p44 Erk activation with PC cell migration, invasion, RhoC GTPase and p38 MAPK activation. Furthermore, inhibition of RhoC or p38 activity in HPAF-II cells leads to partial restoration of cav-1 expression.
Cav-1 expression inhibits RhoC GTPase activation and subsequent activation of the p38 MAPK pathway in primary PC cells thus restricting migration and invasion. In contrast, loss of cav-1 expression leads to RhoC-mediated migration and invasion in metastatic PC cells.

1 Bookmark
 · 
155 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Caveolin-1 is a transmembrane protein and essential structural constituent of the caveolae membrane. Caveolin-1 has been involved in multiple cellular functions and oncogenesis. To investigate the roles of caveolin-1, stable transfectants were established in PANC1 pancreatic adenocarcinoma cells which had up-regulated caveolin-1 expression. The plasmid pCI-neo-cav-1 and its corresponding empty vector (pCI-neo) were transfected into PANC1 cell lines. The expression of caveolin-1 in these three cell lines was determined by RT-PCR and Western blot. Cell cycle phase distribution was determined by flow cytometry. The colony formation ability of tumor cells was detected by anchorage-independent growth assay. Cell migration and invasion were assayed in MilliCell chambers. Xenograft tumor models in nude mice were developed. Immunohistochemistry was used to characterize Ki-67 levels in residual tumors, and apoptosis was evaluated by TUNEL technique. Caveolin-1 overexpression inhibited PANC1 cell proliferation by arresting the cell cycle in the G0/G1 phases and also markedly reduced the capacity of the cells to form colonies in soft agar. Additionally, caveolin-1 overexpression dramatically inhibited cells to invade and migrate. Importantly, in vivo experiments demonstrated that overexpression of caveolin-1 resulted in significant growth inhibition of the xenograft pancreatic tumors. Immunohistochemistry analysis demonstrated both a marked decrease in the number of proliferating tumor cells and an increase in the number of apoptotic tumor cells in PANC1/cav-1 xenograft tumors. The results provide an initial demonstration that caveolin-1 can function as a tumor suppressor rather than as a tumor promoter in PANC1 cells.
    Progress in Biochemistry and Biophysics 12/2012; 38(12):1121-1131. DOI:10.3724/SP.J.1206.2011.00168 · 0.29 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Even though tremendous advances have been made in the treatment of cancers during the past decades, success rate among cancer patients is still dismal largely due to problems associated with chemo/radio-resistance and relapse. Emerging evidence has indicated that cancer stem cells (CSCs) are behind the resistance and recurrence problems, but our understanding of their regulation is limited. Rapid reversible changes of CSC-like cells within tumors may result from the effect of biological mediators found in tumor microenvironment. Here we show how nitric oxide (NO), a key cellular modulator whose level is elevated in many tumors, affects CSC-like phenotypes of human non-small-cell lung carcinoma (NSCLC) H292 and H460 cells. Exposure of NO gradually altered the cell morphology towards mesenchymal stem-like shape. NO exposure promoted CSC-like phenotype indicated by increased expression of known CSC markers, CD133 and ALDH1A1, in the exposed cells. This effect of NO on stemness was reversible after cessation of the NO treatment for 7 days. Furthermore, such effect was reproducible using another NO-donor, S-nitroso-N-acetylpenicillamine (SNAP). Importantly, inhibition of NO by known NO scavenger 2-(4-carboxy-phenyl)-4,4,5,5 tetramethylimidazoline-1-oxy-3-oxide (PTIO) strongly inhibited CSC-like aggressive cellular behavior and marker expression. Lastly, we unveiled the underlying mechanism of NO action through the activation of caveolin-1 (Cav-1) which is upregulated by NO and is responsible for the aggressive behavior of the cells, including anoikis resistance, anchorage-independent cell growth, and increased cell migration and invasion. These findings indicate a novel role of NO in CSC regulation and its importance in aggressive cancer behaviors through Cav-1 upregulation. Copyright © 2014, American Journal of Physiology - Cell Physiology.
    AJP Cell Physiology 11/2014; 308(2):ajpcell.00187.2014. DOI:10.1152/ajpcell.00187.2014 · 3.71 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Caveolin-1 (Cav-1) is found predominately in terminally differentiated cells, such as adipocytes, endothelia and smooth muscle cells, as well as type I pneumocytes. As a main structural component of caveolae, Cav-1 is important in modulating cellular signaling. In the present study, the expression and clinical role of Cav-1 were analyzed in tumor stromal and human cancer cells, respectively. The results of previous studies have shown that the downregulation of tumor stromal Cav-1 promotes tumor survival and predicts a poor tumor prognosis, predominantly concentrating on the mechanism of the metabolism of the cancer microenvironment (according to the autophagic tumor stroma model of cancer metabolism and the reverse Warburg effect). However, contradictory results concerning the expression, clinical roles and associated mechanisms of Cav-1 have been reported. An improved understanding of Cav-1 expression in tumor stromal and cancer cells will increase knowledge with regard to the clinical value of Cav-1 and its detailed mechanisms. This review summarizes the novel data concerning the clinical values and probable mechanisms of Cav-1 expression in tumor stromal (predominantly in cancer-associated fibroblasts) and cancer cells, respectively.
    Oncology letters 10/2014; 8(4):1409-1421. DOI:10.3892/ol.2014.2385 · 0.99 Impact Factor

Preview

Download
0 Downloads
Available from